scieee Science in your language
[en] (orig)

Effectiveness of needle and syringe Programmes in people who inject drugs : an overview of systematic reviews

Abstract

Background: Needle and syringe programmes (NSP) are a critical component of harm reduction interventions among people who inject drugs (PWID). Our primary objective was to summarize the evidence on the effectiveness of NSP for PWID in reducing blood-borne infection transmission and injecting risk behaviours (IRB). Methods: We conducted an overview of systematic reviews that included PWID (excluding prisons and consumption rooms), addressed community-based NSP, and provided estimates of the effect regarding incidence/prevalence of Human Immunodeficiency Virus (HIV), Hepatitis C virus (HCV), Hepatitis B virus (HBV) and bacteremia/sepsis, and/or measures of IRB. Systematic literature searches were undertaken on relevant databases, including EMBASE, MEDLINE, and PsychINFO (up to May 2015). For each review we identified relevant studies and extracted data on methods, and findings, including risk of bias and quality of evidence assessed by review authors. We evaluated the risk of bias of each systematic review using the ROBIS tool. We categorized reviews by reported outcomes and use of meta-analysis; no additional statistical analysis was performed. Results: We included thirteen systematic reviews with 133 relevant unique studies published between 1989 and 2012. Reported outcomes related to HIV (n = 9), HCV (n = 8) and IRB (n = 6). Methods used varied at all levels of design and conduct, with four reviews performing meta-analysis. Only two reviews were considered to have low risk of bias using the ROBIS tool, and most included studies were evaluated as having low methodological quality by review authors. We found that NSP was effective in reducing HIV transmission and IRB among PWID, while there were mixed results regarding a reduction of HCV infection. Full harm reduction interventions provided at structural level and in multi-component programmes, as well as high level of coverage, were more beneficial. Conclusions: The heterogeneity and the overall low quality of evidence highlights the need for future community-level studies of adequate design to support these results.

Read accessible full text

Effectiveness of needle and syringe Programmes in people who inject drugs : an overview of systematic reviews

Author: Fernandes, Ricardo M.,Cary, Maria,Duarte, Gonçalo,Jesus, Gonçalo,Alarcão, Joana,Torre, Carla,Costa, Suzete,Costa, João,Carneiro, António Vaz
Publisher: BioMed Central
Year: 2017
Source: https://repositorio.ulisboa.pt/bitstream/10451/32123/1/Effectiveness_needle_syringe.pdf
RESEARCH ARTICLE Open Access
E ec i eness o needle and sy inge
P og ammes in people who injec d ugs –
An o e iew o sys ema ic e iews
Rica do M Fe nandes
1,3
, Ma ia Ca y
2
, Gonçalo Dua e
1
, Gonçalo Jesus
1
, Joana Ala cão
1
, Ca la To e
2
, Suze e Cos a
2
,
João Cos a
1,3
and An ónio Vaz Ca nei o
1,3*
Abs ac
Backg ound: Needle and sy inge p og ammes (NSP) a e a c i ical componen o ha m educ ion in e en ions among
people who injec d ugs (PWID). Ou p ima y objec i e was o summa ize he e idence on he e ec i eness o NSP o
PWID in educing blood-bo ne in ec ion ansmission and injec ing isk beha iou s (IRB).
Me hods: We conduc ed an o e iew o sys ema ic e iews ha included PWID (excluding p isons and consump ion
ooms), add essed communi y-based NSP, and p o ided es ima es o he e ec ega ding incidence/p e alence o
Human Immunode iciency Vi us (HIV), Hepa i is C i us (HCV), Hepa i is B i us (HBV) and bac e emia/sepsis, and/o
measu es o IRB. Sys ema ic li e a u e sea ches we e unde aken on ele an da abases, including EMBASE, MEDLINE,
and PsychINFO (up o May 2015). Fo each e iew we iden i ied ele an s udies and ex ac ed da a on me hods, and
indings, including isk o bias and quali y o e idence assessed by e iew au ho s. We e alua ed he isk o bias o each
sys ema ic e iew using he ROBIS ool. We ca ego ized e iews by epo ed ou comes and use o me a-analysis; no
addi ional s a is ical analysis was pe o med.
Resul s: We included hi een sys ema ic e iews wi h 133 ele an unique s udies published be ween 1989 and 2012.
Repo ed ou comes ela ed o HIV (n=9),HCV(n= 8) and IRB (n= 6). Me hods used a ied a all le els o design and
conduc , wi h ou e iews pe o ming me a-analysis. Only wo e iews we e conside ed o ha e low isk o bias using
he ROBIS ool, and mos included s udies we e e alua ed as ha ing low me hodological quali y by e iew au ho s. We
ound ha NSP was e ec i e in educing HIV ansmission and IRB among PWID, while he e we e mixed esul s
ega ding a educ ion o HCV in ec ion. Full ha m educ ion in e en ions p o ided a s uc u al le el and in
mul i-componen p og ammes, as well as high le el o co e age, we e mo e bene icial.
Conclusions: The he e ogenei y and he o e all low quali y o e idence highligh s he need o u u e communi y-le el
s udies o adequa e design o suppo hese esul s.
T ial egis a ion: The p o ocol o his sys ema ic e iew was egis e ed in P ospec i e Regis e o Sys ema ic Re iews
(PROSPERO 2015:CRD42015026145).
Keywo ds: Needle and sy inge p og ammes, Ha m educ ion in e en ions, People who injec d ugs, HIV/Aids-Hc -Hb
* Co espondence: [email p o ec ed]
1
Cen e o E idence-Based Medicine, Facul y o Medicine, Uni e si y o
Lisbonl, A . P o . Egas Moniz, 1649-028 Lisbon, Po ugal
3
Po uguese Collabo a ing Cen e o he Ibe oAme ican Coch ane
Ne wo k-Coch ane Po ugal Facul y o Medicine, Uni e si y o Lisbon, A .
P o . Egas Moniz, 1649-028 Lisbon, Po ugal
Full lis o au ho in o ma ion is a ailable a he end o he a icle
© The Au ho (s). 2017 Open Access This a icle is dis ibu ed unde he e ms o he C ea i e Commons A ibu ion 4.0
In e na ional License (h p://c ea i ecommons.o g/licenses/by/4.0/), which pe mi s un es ic ed use, dis ibu ion, and
ep oduc ion in any medium, p o ided you gi e app op ia e c edi o he o iginal au ho (s) and he sou ce, p o ide a link o
he C ea i e Commons license, and indica e i changes we e made. The C ea i e Commons Public Domain Dedica ion wai e
(h p://c ea i ecommons.o g/publicdomain/ze o/1.0/) applies o he da a made a ailable in his a icle, unless o he wise s a ed.
Fe nandes e al. BMC Public Heal h (2017) 17:309
DOI 10.1186/s12889-017-4210-2
Backg ound
People who injec d ugs (PWID) expe ience high le els o
mo bidi y and mo ali y. D ug- ela ed ha ms include o e -
dose, d ug- ela ed dea hs, and blood-bo ne in ec ions
such as Human Immunode iciency Vi us (HIV), Hepa i is
C (HCV), Hepa i is B (HBV), and bac e emia/sepsis. HCV
is cu en ly he mos p e alen in ec ious disease a ec ing
PWID, while HIV p e alence a es a e lowe . In an es i-
ma ed o al o 12.7 o 16 million PWID wo ldwide, i is
belie ed ha 1.2 million a e in ec ed wi h HIV [1] and 10
million a e in ec ed wi h HCV [2]. Sha ing needles and
sy inges, as well as o he injec ing pa aphe nalia, is a key
ou e o ansmission o hese in ec ions [3].
Needle and sy inge p og ammes (NSP) a e hough o
be a c i ical componen o ha m educ ion in e en ions
among PWID [3, 4]. The i s NSP was es ablished in he
1980s [5], in esponse o he global HIV epidemic, wi h
he goal o p o iding access and encou aging he use o
s e ile injec ion pa aphe nalia by PWID. Since hen,
p o ision o hese se ices has g own apidly. Impo an ly,
a shi in pa adigm has a ou ed NSP as componen s o
ha m educ ion o ha m minimiza ion policies, which
ocus on educing all d ug- ela ed ha ms, i.e. p e en ing
HIV, HBV and HCV in ec ion, minimizing needle and
sy inge sha ing and euse, educing he olume o dis-
ca ded needles and sy inges in he en i onmen , and a-
cili a ing access o s e ile pa aphe nalia. Fu he mo e,
NSP may also p omo e he use o condoms and p o ide
oppo unis ic ele an heal h in o ma ion and se ices [3].
NSP a e complex heal h in e en ions wi h se e al
in e ac ing componen s, such as beha iou al changes in
PWID and p o ide s, a complex ope a ing amewo k
(use s, p o ide s, se ing, heal h sys ems), and some
deg ee o lexibili y o in e en ions [6]. The e is consid-
e able a iabili y among egions and coun ies in se ice
p o ision, co e age and ange o ha m educ ion in e -
en ions o e ed by NSP. In pa icula , a a ie y o
measu es ha e been de eloped o imp o e access o and
use o s e ile injec ing equipmen and o inc ease use s’
choice. These include se e al me hods o dis ibu ion o
sale such as con en ional NSP in ixed-si es, pha macy-
based dis ibu ion, dispensing machines and ou each
p og ammes –o en using a mobile an o bus, o
h ough home- isi s [3]. Gene ally, pha macy and
specialis needle exchange p o ides a wide ange o
ha m educ ion in o ma ion and ad ice, along wi h clean
needles and sy inges and possibly injec ing pa aphe na-
lia. The legal amewo k in which NSP ope a e also
a ies a coun y le el [7]. Pha macy-based NSP a e known
o be in place in a leas Aus alia [8], Belgium, F ance,
I eland, Ky gyzs an, he Ne he lands, Po ugal, Spain,
Slo enia, Uk aine [7, 9], UK [10], and New Zealand [11].
Many sys ema ic e iews on he e ec i eness o in e -
en ions p o iding injec ing equipmen ha e been
conduc ed o da e. O e iews o e iews which compile
in o ma ion om hese mul iple sys ema ic e iews, ha e
also been published. The aim o hese o e iews is o
p o ide end-use s wi h a comp ehensi e and c i ical
summa y o he a ailable e idence on his in e en ion.
O e iews a e o pa icula in e es in his ield because
exis ing sys ema ic e iews ha e ocused on dispa a e
ques ions, ega ding ei he speci ic popula ions (e.g.
coun y-speci ic e idence), speci ic ypes o in e en ions
(e.g. di e en ypes o NSP p o ision) o , mos
commonly, speci ic ou comes (e.g. HIV o HCV ans-
mission) [12–14]. Fu he mo e, he e is a iabili y in
me hods used in hese sys ema ic e iews, including he
assessmen o possible biases and he use o quan i a i e
syn hesis (me a-analysis). Ne e heless, o he bes o
ou knowledge, he published o e iews in his ield
ha e ocused only on speci ic ou comes, i.e. ansmission
o HIV and/o HCV.
Objec i es
Ou p ima y objec i e was o conduc an o e iew o
sys ema ic e iews ha e alua ed he e idence o he
e ec i eness o NSP o PWID ac oss a ange o di e -
en ele an ou comes, i.e. blood-bo ne in ec ion ans-
mission and injec ing isk beha iou s (IRB).
Ou seconda y objec i e was o assess how di e en
aspec s o NSP p o ision, including p o ide , se ing,
co e age and any ela ed componen deli e ed in
pa allel, such as ha m educ ion se ices and opia e
subs i u ion he apy, modi ied he e ec o NSP, wi h a
pa icula ocus on pha macy-d i en NSP.
Me hods
We ollowed cu en guidance on he conduc o
o e iews o e iews, including ecommenda ions om
he Coch ane Collabo a ion [15] and guidance on
public heal h in e en ion e iews by he Cen e o
Re iews and Dissemina ion o he Uni e si y o Yo k
[16]. We also ollowed he ecommenda ions om he
PRISMA-P s a emen ega ding epo ing i ems ha we
conside ed applicable o his o e iew [17]. The p o ocol
o his o e iew was egis e ed a PROSPERO
(CRD42015026145) a ailable a h p://www.c d.yo k.ac.uk/
PROSPERO/display_ eco d.asp?ID=CRD42015026145.
Eligibili y c i e ia
Fo inclusion in his o e iew, s udies had o mee he
ollowing c i e ia:
1. S udy design: sys ema ic e iews, ope a ionally de ined
as s udies epo ing a clea ly s a ed se o objec i es,
eligibili y c i e ia, a sys ema ic sea ch using wo o
mo e sou ces, a sys ema ic p esen a ion o he
cha ac e is ics and indings o he included s udies,
Fe nandes e al. BMC Public Heal h (2017) 17:309 Page 2 o 15
and es ima es o he size and di ec ion o he e ec o
in e en ions p esen ed as nume ical da a, on an
indi idual s udy-le el basis and/o wi h quan i a i e
syn hesis (me a-analysis);
2. Pa icipan s: PWID, de ined as people who injec
some o m o d ug a he beginning o he s udy.
We excluded s udies ocusing exclusi ely on pa icipan s
whose consump ion was con ined o p isons and
consump ion ooms, since hese a e popula ions wi h
dis inc cha ac e is ics om ou a ge popula ion;
3. In e en ions: sys ema ic e iews had o e alua e
communi y-based NSP, de ined as he supply o a
leas needles and sy inges, wi h o wi hou o he
injec ing pa aphe nalia o he p epa a ion and
consump ion o d ugs;
4. Ou comes: equi ed epo ed ou comes included he
incidence and/o p e alence o blood-bo ne in ec ions
(HIV, HCV, HBV and bac e emia/sepsis), and/o
measu es o IRB (including bu no limi ed o sy inge
e-use, bo owing, sha ing, en ing and lending).
When mo e han one e iew included exac ly he same
s udies, he e iew ha epo ed he mos comple e p esen-
a ion o esul s was selec ed o inclusion in he o e iew.
Sea ch s a egy and sc eening
Sea ches we e unde aken on MEDLINE®In-P ocess &
O he Non-Indexed Ci a ions ( om 1946 o 12 h o
May 2015), EMBASE ( om 1974 o 12 h o May 2015)
and PsycINFO ( om 1806 o 12 h o May 2015) ia he
OVID SP in e ace. In addi ion, he ollowing da abases
we e sea ched: he NHS Economic E alua ion Da abase
(NHS EED), he Da abase o Abs ac s o Re iews o
E ec s (DARE), he Coch ane Da abase o Sys ema ic
Re iews (CDSR), he Na ional Ins i u e o Heal h and
Clinical Excellence (NICE), he Campbell Lib a y o
Sys ema ic Re iews and he Da abase o P omo ing Heal h
E ec i eness Re iews (DoPHER). The sea ch s a egies o
each da abase a e shown in a supplemen a y ile
(Addi ional ile 1). No language o o he ypes o es ic-
ions we e applied. In addi ion o he da abase sea ches,
handsea ching o he e e ences o he included e iews
was unde aken o iden i y u he ele an s udies.
Ti les and abs ac s o a icles iden i ied we e sc eened
independen ly by wo au ho s (MC, JA), and classi ied as
include, unclea o exclude. The ull epo s o all
a icles ha classi ied as include o unclea we e hen
ob ained, and wo au ho s (MC, GD) examined compli-
ance o e iews wi h eligibili y c i e ia, wi h a hi d
au ho ac ing as an a bi e (RF).
Da a ex ac ion
Da a om epo s o all included sys ema ic e iews
we e ex ac ed by wo au ho s (MC, GD) and alida ed
by a hi d au ho (RF), using a da a ex ac ion o m
designed and p e-pilo ed o his o e iew. The ollow-
ing gene al cha ac e is ics we e ex ac ed om each
sys ema ic e iew: publica ion de ails; s udy objec i es;
eligibili y c i e ia (popula ion, in e en ion, compa a o s,
ou comes, s udy designs); any epo ed p o ocol; and
me hods used o sea ch, sc eening, da a ex ac ion and
syn hesis. Fo each sys ema ic e iew, we lis ed all in-
cluded s udies and e alua ed whe he hey ma ched he
eligibili y c i e ia o his o e iew ega ding popula ion,
in e en ions and ou comes. We hen ex ac ed he
ollowing esul s om he eligible g oup o s udies,
whene e epo ed a he sys ema ic e iew le el: s udy
design; coun ies in ol ed; cha ac e is ics o included
pa icipan s (demog aphics, p e alence o HIV/HCV);
desc ip ion o in e en ions and any co-in e en ion,
du a ion o in e en ion and ollow-up; e ec es ima es
om me a-analysis (i a ailable) o a indi idual s udy-
le el, o each ele an ou come; and any subg oup o
sensi i i y analyses. The au ho s’conclusions o each
ele an ou come we e also collec ed. We con ac ed he
au ho s o e iews o ele an missing da a.
Assessmen o me hodological quali y
A a s udy le el, we ex ac ed da a on any isk o bias
assessmen s o p ima y s udies when pe o med and e-
po ed by e iewe s in each sys ema ic e iew, including
ools used and summa ized esul s. We also collec ed
da a on any epo ed e alua ions o he quali y o
e idence conce ning ou ou comes o in e es in
included e iews, pa icula ly hose using he G ading o
Recommenda ions Assessmen , De elopmen and E alu-
a ion (GRADE) ool [18], as well as da a on assessmen s
o publica ion bias.
A a sys ema ic e iew le el, we assessed he me hodo-
logical quali y o each included sys ema ic e iew using
he Risk O Bias In Sys ema ic Re iews (ROBIS) ool [19].
Two e iew au ho s (MC, RF) pe o med quali y assess-
men s independen ly, using pilo ed decision ules. Dis-
ag eemen s ega ding o e all assessmen s we e esol ed
h ough discussion, wi h a hi d e iewe se ing as he
inal a bi a o (AVC). The a ionale behind assessmen s
was documen ed. We calcula ed measu es o ag eemen
and eliabili y be ween a e s o each ROBIS domain.
Da a syn hesis
We s a i ied he included sys ema ic e iews by: (i) ype
o ou comes assessed (blood-bo ne in ec ions, IRB), and
(ii) ype o analysis (wi h o wi hou me a-analysis). We
summa ized da a om he included e iews bo h in ex
and in summa y ables and igu es. When me a-analysis
was pe o med, we epo pooled es ima es using he
models and measu es o e ec epo ed by sys ema ic e-
iew au ho s, wi h 95% con idence in e als (95% CI);
Fe nandes e al. BMC Public Heal h (2017) 17:309 Page 3 o 15
we did no pe o m any addi ional s a is ical analysis.
When epo ed, he accompanying I
2
alues, which
desc ibe he pe cen age o o al a ia ion ac oss s udies
ha is due o he e ogenei y a he han chance, we e
collec ed [20].
Resul s
The sea ch and sc eening p ocess is summa ised in
Fig. 1. A o al o 667 ci a ions we e iden i ied h ough
he a ious da abase sea ches. Th ee addi ional e-
co ds we e iden i ied in he e e ence lis s o sc eened
s udies. A e 37 duplica es we e emo ed, we ob ained
633 ci a ions, which we e sc eened by i le and abs ac .
We excluded 582 ci a ions as hey did no mee he inclu-
sion c i e ia, and he emaining 51 we e sc eened ull ex .
Thi y- i e ci a ions we e u he excluded, and wo
epo s [21, 22] we e unob ainable. Fou een epo s
we e hus included, co esponding o 13 sys ema ic
e iews, as wo eco ds e e ed o he same s udy
[12, 23]. Wi hin hose publica ions h ee we e epo s
om Na ional Ins i u es/Expe Commi ees in he US
[24], UK [12] and Canada [25], while 10 we e egula
pape s published in scien i ic jou nals.
Desc ip ion o included e iews
Table 1 lis s he key cha ac e is ics o he 13 included
sys ema ic e iews ha e alua ed he e idence o he
e ec i eness o NSP o PWID in he communi y se -
ing. We classi ied e iews by ype o ou comes epo ed
and ype o da a analysis (Fig. 2).
The numbe o da abases sea ched pe e iew a ied
be ween wo and 15, wi h he h ee mos common
sou ces being MEDLINE, EMBASE and PsycINFO. The
da es o las sea ch a ied be ween 1995 [26] and 2012
[27]. O 287 s udies included in hese 13 e iews, 200
s udies ma ched he eligibili y c i e ia o his o e iew,
co esponding o 133 unique s udies (a ma ix wi h
included s udies by e iew is a ailable in a supplemen-
a y ile: Addi ional ile 2). We included he comple e se
o s udies om ou e iews, as in he emaining e iews a
leas one s udy did no ul ill ou eligibili y c i e ia [27–30].
The numbe o ele an s udies included pe e iew anged
om h ee [31, 32] o 43 [24]. While he e was some
o e lap in he included s udies be ween e iews, he majo -
i y (68%) was included in one e iew only.
We ound subs an ial a iabili y in he c i e ia used by
e iew au ho s o de ine and classi y s udy designs, as well
Fig. 1 Sc eening decisions up o da e as o 30Jun2015. O iginal sea ch da e 12May2015
Fe nandes e al. BMC Public Heal h (2017) 17:309 Page 4 o 15
Table 1 Key cha ac e is ics o he included sys ema ic e iews and Risk o bias o each e iew
Au ho s, da e o
publica ion
a
PICOS
b
Da es o las
sea ch
Da abases sea ched (n) Risk o Bias and quali y o
e idence ools
To al numbe o s udies/
Numbe o s udies ele an
o he o e iew (designs)
c,d
Risk o bias o he
e iew (assessed
using ROBIS ool)
Quan i a i e syn hesis- me a-analysis
Aspinall,
2014 [27]
P: PWID
I: NSP (Specialis si es, pha macies o
ou each se ices)
C: No, a e, o less exposu e o NSP
O: HIV incidence
S: any
2012 CINAHL, Coch ane Lib a y, EMBASE,
IBSS, MEDLINE and PsycINFO (6)
Newcas le-O awa each s udy &
GRADE o assess quali y o
e idence as a whole
12/12 (11 CC/Co; 1 OTH) Low
Hagan, 2011 [34] P: indi iduals who could concei ably
ha e acqui ed HCV in ec ion ia
adminis a ion o an illegal d ug (PWID
among hem)
I: in e en ions ha could p e en HCV
in ec ion
C:NR
O: HCV p e alence o incidence a es,
and measu es o associa ion wi h
p e alence o incidence
S: any
2010 Cu en Con en s, Disse a ion
Abs ac s, ERIC, NIH CRISP, MEDLINE,
PsycINFO, Sociological Abs ac s (7)
De eloped hei own quali y
scale
26/7 (7 CC/Co) High
Tu ne , 2011 [32] P: PWID in he UK
I: NSP o OST (o combina ion)
C: OST s non OST; high s low
co e age o NSP
O: HCV in ec ion and IRB
S: any
NR PubMed and Web o Science (2) None 4/3 (1 CC/Co; 2 OTH) High
C oss, 1998 [26] P: PWID
I: NSP o educa ional p og ammes
C: NR
O: IRB
S: expe imen al o quasi-expe imen al
design
1995 AIDSLINE, MEDLINE, PsycINFO, Social
Science Ci a ion Index (4)
None 26/10 (1 RCT; 9 OTH) High
Quali a i e syn hesis
Abdul-Quade ,
2013 [29]
P: PWID
I: S uc u al in e en ions ha add ess
ex e nal ac o s o educe HIV and HCV
C: any quan i a i e compa ison
O: Changes in HIV/HCV in ela ion o
in e en ion
S: con olled o be o e & a e
2011 Coch ane Cen al Regis e o
Con olled T ials, EMBASE, LILACS,
PsycINFO, PubMed, and he Web
o Science/Web o Social
Science (6)
WHO-Johns Hopkins 9-Poin
Rigou Scale.
15/15 (1 CC/Co; 14 OTH) Unclea
Des Ja lais, 2013 [28] P: PWID in low-and middle income
and ansi ional coun ies (LMICs)
I: NSP
C: any
O: changes in p e alence o incidence
o HIV, HCV, HIV/ HCV co-in ec ion o
changes o e ime in newly epo ed
HIV o HCV cases o in ec ion
S: any
2011 EMBASE, NLM Ga eway, PubMed,
Web o Science (4)
None 13/13 (13 OTH) High
Fe nandes e al. BMC Public Heal h (2017) 17:309 Page 5 o 15

Table 1 Key cha ac e is ics o he included sys ema ic e iews and Risk o bias o each e iew (Con inued)
Hong and Li,
2009 [31]
P: People wi h HIV/ AIDS in China
I: Any beha iou al in e en ion
C: Any
O: Ra e o needle-sha ing
S: Any
2008 AIDSLine, EBSCO, Fi s Sea ch,
PsycINFO, PubMed (4)
None 25/3 (1 RCT; 1 CC/Co; 1
OTH)
High
Jones, 2008 [12] P: PWID
I: NSP
C: any
O: IRB, HIV, HVC
S: RCT, con olled non- andomised
s udies, con olled and uncon olled
be o e and a e s udies, c oss-sec ional
s udies, coho s udies, case-con ol
s udies and ecological s udies
2008 ACP Jou nal Club, ASSIA, CINAHL,
Coch ane Lib a y,
EMBASE, EPPI-Cen e da abases,
Heal h In o ma ion Managemen
Conso ium, IBSS, MEDLINE,
Na ional Resea ch Regis e
A chi e, OpenSIGLE, P ojec CORK,
PsycINFO,
Sociological Abs ac s,
SOMED (15)
Quali y assessmen ools
de eloped by NICE Cen e o
Public Heal h Excellence, England
and Wales and he E ec i e Public
Heal h P ac ice P ojec , Canada
24/15 (2 RCT; 1 CC/Co; 12
OTH)
Low
Kall, 2007 [30] P: PWID
I: NSPs
C: con ol o compa ison g oups
O: HIV incidence o p e alence
S: any
2005 MEDLINE and PsyclNFO (2) None 16/16 (8 CC/Co; 8 OTH) High
W igh , 2006 [33] P: PWID
I: p ima y p e en ion in e en ion
a ge ing injec ing d ug use
C: any
O: HCV p e alence and incidence
S: in e en ion o obse a ional s udies
2003 Coch ane Lib a y, CINAHL,
EMBASE, MEDLINE and PsycINFO (4)
De eloped hei own quali y scale 18/12 (9 CC/Co; 3 OTH) High
Tilson, 2006 [24] P: PWID
I: NSP
C: Wi h and wi hou OST; Placebo.
O: IRB, HCV and HIV
S: NR
2006 Coch ane Lib a y, G ey Li e a u e
Repo , EMBASE, PubMed,
PsycINFO, Social Science
Abs ac s, Web o Science,
Wo ldCa (8)
GRADE 45/43 (28 CC/Co; 15 OTH) Unclea
Gibson, 2001 [35] P:PWID
I:NSP
C: any
O:HIV, HBV, HCV and IRB
S:any
1999 Medline and PsycINFO (2) None 42/32 (19 CC/Co; 13 OTH) High
Leona d, 1999 [25] P: PWID
I: NSP
C: Any compa a o g oup (bu none
was no allowed)
O: HIV, HCV and IRB
S: NR
1999 AIDSLINE, CINAHL, Coch ane
Lib a y, EMBASE, MEDLINE,
PHE ec (6)
Quali y assessmen ools de eloped
by he E ec i e Public Heal h P ac ice
P ojec eam, Canada
21/19 (15 CC/Co; 4 OTH) Unclea
a
Ca ego ized by ype o syn hesis and lis ed by publica ion da e
b
PICOS: ac onym o Popula ion, In e en ion, Compa a o , Ou come and S udy Design
c
Classi ied by au ho s o he e iew
d
CC/Co: Case-Con ol/Coho ; RCT: Randomized Con ol T ial; OTH: o he ( ime-se ies designs, be o e-a e s udies, ecological s udies)
Fe nandes e al. BMC Public Heal h (2017) 17:309 Page 6 o 15
as ypes o designs o included s udies. Only ou e iews
speci ied he ypes o s udy design in hei eligibili y
c i e ia [12, 26, 29, 33]. Th ee e iews included andom-
ized con olled ials ( ou RCTs o e all) [12, 26, 31], while
he emaining e iews included coho s and case-con ols
(101 o e all), as well as o he s udy designs ( ime se ies,
be o e/a e s udies o ecological s udies) (95 o e all).
Th ee o he included e iews we e es ic ed o
s udies conduc ed in speci ic coun ies o economic e-
gions (China, UK, and low- and middle-income coun ies)
[28, 31, 32]. Nine e iews epo ed da a on HIV, eigh on
HCV, and six on IRB. Se en e iews e alua ed mo e han
one o hese ou comes. Fou e iews used me a-analysis
[26, 27, 32, 34], one o which using indi idual-pa icipan
da a [32]. The emaining nine e iews used na a i e
syn hesis [12, 24, 25, 28–31, 33, 35]. The easons epo ed
by he au ho s o conduc ing o no conduc ing
me a-analysis a ied be ween e iews, e en when he e
was a deg ee o o e lap be ween included s udies.
Me hodological quali y
Se en e iews epo ed ha ing assessed he me hodo-
logical quali y o included s udies [12, 24, 25, 27, 29, 33, 34].
In wo e iews he au ho s de eloped ad hoc ools [33, 34],
while he emaining e iews used p e iously exis ing
ins umen s, o en wi h modi ica ions ( ools used:
Newcas le-O awa, GRADE, WHO-Johns Hopkins 9-
Poin Rigou Scale, Quali y assessmen ools de el-
oped by NICE Cen e o Public Heal h Excellence,
England and Wales and he E ec i e Public Heal h
P ac ice P ojec , Canada) [12, 24, 25, 27, 29]. Only
wo ins umen s we e used mo e han once, and all
o he ins umen s a ied. No all e iews epo ed he
esul s o hese assessmen s; when epo ed, mos
s udies we e conside ed o ha e low me hodological
quali y, gi en me hodological weaknesses and biases
ela ed o obse a ional s udy designs. Only one
quan i a i e e iew [27] inco po a ed quali y in da a
syn hesis, by conduc ing a sensi i i y analysis. In
e iews wi hou me a-analysis, me hodological quali y
and isk o bias was p esen ed desc ip i ely in he
in e p e a ion o s udy esul s. Two e iews [24, 27]
epo ed using he GRADE ool o assess he quali y
o he body o e idence. One conside ed he o e all
quali yo e idenceaslow[27],while heo he ,using
an adap a ion o GRADE, e alua ed he quali y o
Fig. 2 S udies selec ed o inclusion classi ied by ou come(s) epo ed and s a egy o da a syn hesis. *G ey shaded boxes ep esen he ou come
epo ed in he e iews indica ed in he igh column. “HIV”,”HCV”and “Injec ing isk beha iou s”is used o classi y he e iews ha epo ed he
impac o NSP in he numbe o HIV in ec ions, numbe o HCV in ec ions and change in injec ion beha io . The e iews a e also p esen ed in he
igh column by s a egy used o da a syn hesis
Fe nandes e al. BMC Public Heal h (2017) 17:309 Page 7 o 15
e idence as modes o mode a e o di e en ou -
comes [24].
Using he ROBIS ool, only wo o he included e iews
we e conside ed o ha e low isk o bias, whe eas he
emaining we e conside ed o ha e ei he high (n=8)o
unclea isk o bias (n= 3) (summa y o esul s a ailable in
a supplemen a y ile: Addi ional ile 3). The majo i y o e-
iews we e a ed as ha ing high o unclea isk o bias
ac oss all ROBIS domains, i.e. s udy eligibili y c i e ia, iden-
i ica ion and selec ion o s udies, da a collec ion and s udy
app aisal, syn hesis and indings. Pe cen age o ag eemen
be ween ROBIS a e s a ied be ween 77% and 92%, and
weigh ed kappa (quad a ic) be ween 0.82 and 0.95.
The esul s om he PRISMA-P s a emen applied o
his o e iew a e p esen ed a Addi ional ile 4.
E ec s o NSP
HIV p e alence and/o incidence
O nine e iews ha epo ed da a on HIV ou comes,
wo we e a low isk o bias [12, 27], and only one
pe o med me a-analysis [27]. The p opo ion o s udies
included in only one o hese nine e iews was 71%.
Re iews wi h me a-analysis The mos ecen e iew by
Aspinall e al. included wel e s udies (10 coho , one
case-con ol and one c oss-sec ional s udy), and was
e alua ed as ha ing low isk o bias. The e iew epo ed
a 34% “ isk” educ ion o HIV ansmission (pooled
e ec es ima e o 0.66; 95% CI: 0.43 o 1.01; n=10
s udies; I
2
= 76%) in indi iduals exposed o NSP, com-
pa ed wi h hose who we e no , o we e less equen ly,
exposed o NSP. This es ima e was ob ained by pooling
bo h adjus ed and unadjus ed e ec sizes ega dless o
s udy design, in a andom e ec s model, and pooling all
ypes o e ec measu es (odds a io, isk a io, haza d
a io). Sensi i i y analyses suppo ed hese esul s, wi h a
s a is ically signi ican educ ion in HIV ansmission
associa ed wi h NSP exposu e in bo h highe quali y s ud-
ies (0.42; 95% CI: 0.22 o 0.81), and s udies epo ing ela-
i e isks o haza d a ios (0.60; 95% CI: 0.37 o 0.97).
Subg oup analyses showed ha s udies using sequen ial
ollow-up (i.e. g oups exposed o NSP and g oups no ex-
posed ollowed sequen ially, and no concu en ly) and
s udies ec ui ing pos -1990 had lowe e ec es ima es
(0.21 [95% CI: 0.11 o 0.41] and 0.52 [95% CI: 0.28 o
0.95], espec i ely). Fu he , s udies compa ing 100% NSP
co e age (i.e. clean needle and sy inge used o 100% o
injec ions) wi h <100% NSP co e age gene a ed a pooled
e ec es ima e o 0.58 (95% CI: 0.22 o 1.57). Quali y o
e idence was conside ed low using GRADE, and mos o
hese esul s had subs an ial he e ogenei y.
Re iews wi hou me a-analysis The quan i a i e esul s
p esen ed abo e a e suppo ed by mos e iews wi h
quali a i e summa ies o he e idence only, all o which
published be ween 1999 and 2013. Di e ences be ween
e iews could be ound ega ding eligibili y c i e ia (e.g.
ype o NSP, popula ion- s indi idual-le el ou comes,
s udy design), sea ch and sc eening me hods, quali y
assessmen s and in e p e a ion o s udy esul s. In mos
o hese e iews, he au ho s desc ibed and con ex ual-
ized esul s om each indi idual s udy o g oup o
s udies ega ding HIV ou comes. Some e iews used
o e coun ing o compa e he numbe o posi i e s udies
wi h educ ion in HIV ansmission, wi h he numbe o
nega i e s udies. In he ollowing pa ag aphs, we p esen
he main esul s o hese e iews, s a ing wi h hose
ocusing on he impac o di e en aspec s o NSP
p o ision ollowed by esul s o e iews ocusing exclu-
si ely on he compa ison be ween NSP andno NSP.
Rega ding aspec s o NSP p o ision, Jones and
colleagues epo ed esul s om a ecen sys ema ic e-
iew classi ied as low isk o bias, ha ocused on le el
o co e age, sy inge dispensa ion policies, ype o NSP,
p o ision o addi ional ha m- educ ion se ices and o
opia e subs i u ion he apy [12]. Au ho s judged ha he
ange o s udy designs, in e en ion app oaches exam-
ined and ou comes p ecluded he use o me a-analysis.
Only h ee s udies ocused on HIV ou comes. A low-qu-
ali y s udy showed no signi ican end o HIV p e a-
lence when compa ing p ima y sou ces o needles
(pha macies, ixed si e NSP and an-based NSP),
al hough HIV p e alence was lowe among pha macy
use s han in pa icipan s who epo ed using an o
ixed si e NSP (16% s. 21% and 25%, espec i ely,
p= 0.16) [36]. Ano he s udy [37] included in his
e iew examined he impac o dispensa ion policies,
and no ed a dec ease in HIV p e alence (based on es -
ing o sel - epo ) be ween he pe iod o legal pha macy
sy inge pu chase and when up o i e needles could be
exchanged a newly es ablished NSP (35% o 22%;
p< 0.05). Finally, one mode a e quali y coho s udy
[38] also included in he e iew by Jones and colleagues
e alua ed di e en le els o ha m educ ion and ound
ha a ull ha m educ ion s a egy (combina ion o
me hadone ea men and ull pa icipa ion in NSP)
educed he incidence o HIV when compa ed o incom-
ple e o no ha m educ ion (incidence a e a io: 0.32;
95% CI: 0.17 o 0.62).
In line wi h hese esul s, a e iew wi h an o e all
unclea isk o bias by Abdul-Quade e al. [29] iden i-
ied s udies wi h s uc u al-le el NSP, ie in e en ions in
which changes in policy and legal en i onmen ha e
acili a ed an inc eased a ailabili y o s e ile sy inges,
and ocused on popula ion-le el ou comes. The ope -
a ional de ini ion o s uc u al-le el NSP was a
minimum 50% co e age o PWID and dis ibu ion o 10
o mo e needles/sy inge pe PWID pe yea . Nine s udies
Fe nandes e al. BMC Public Heal h (2017) 17:309 Page 8 o 15
included in his e iew epo ed dec eases in HIV p e a-
lence, and h ee epo ed dec eases in HIV incidence. All
s udies we e non- andomized be o e-a e compa isons o
in e up ed ime se ies analyses, and mos showed
e idence o po en ial selec ion biases. The au ho s con-
cluded ha hese esul s suppo NSP as a s uc u al-le el
in e en ion o educe popula ion-le el in ec ion.
Fou olde published e iews wi h quali a i e syn hesis
and an o e all unclea o high isk o bias epo ed
mixed indings ega ding he impac o NSP on HIV in-
cidence/p e alence. These e iews p o ide a his o ical
pe spec i e on he e olu ion o NSP implemen a ion
and e alua ion. The i s published e iew by Leona d
e al. [25], was an upda e o a p e ious sys ema ic
e iew. Gibson e al. [35] included six s udies published
up o 1999 wi h a ange o s udy designs, pa icipan s
and se ings, epo ing on HIV ou comes. The Ins i u e
o Medicine’s e idence epo [24], iden i ied 12 ele an
s udies, including coho , case-con ol and ecological
designs, as well as s udies using ma hema ical models.
Finally, he e iew by Kall e al. [30] included 16 s udies
published up o 2005, only wo o which we e no
included in o he e iews om his o e iew.
All hese e iews included landma k p ospec i e
coho s udies conduc ed in Mon eal and Vancou e in
he 1990s [39, 40], which ound an associa ion be ween
NSP pa icipa ion and highe isk o HIV se ocon e -
sion. This led Leona d e al. o conclude ha he e was
me hodologically weak e idence ha NSP we e no as
e ec i e as p e iously ound in modi ying HIV p e a-
lence and incidence among PWID. Kall e al. used o e
coun ing and epo ed ha on mos s udies assessing
se oincidence he e ec o NSP was no signi ican ,
while ou s udies in es iga ing se op e alence a base-
line we e un a ou able o NSP. The au ho s also s a ed
ha in s udies ha ound posi i e e ec s, con ounde s
had no been adequa ely con olled o . Howe e , based
on epidemiological e idence ha accumula ed p og es-
si ely, au ho s o he o he e iews highligh ed a
numbe o selec ion biases ha could accoun o
hese indings, including: he inclusion o high- isk
cocaine injec o s, who injec ed mo e o en han
he oin use s; he limi ed numbe o needles and sy-
inges ha use s could ha e access o in ea ly NSP;
and he eady a ailabili y o clean injec ing equipmen
h ough pha macies which could ha e a ac ed
ma ginalized, pa icula ly high- isk indi iduals.
Follow-up s udies in he same se ings, conduc ed a e
expanding and adjus ing NSP (e.g. by allowing unlimi ed
dis ibu ion o needles/sy inges, inc easing he numbe o
access poin s, and o e ing di e en dis ibu ion me hods),
ound no such inc ease in isk, o a dec ease in HIV
p e alence. Gibson e al. [35] used o e coun ing and con-
side ed he e was subs an ial e idence ha NSP we e
e ec i e in p e en ing HIV se ocon e sion. Tilson e al.
[24] included ou ecological s udies ha ound an associ-
a ion be ween HIV p e en ion p og ammes ha include
NSP wi h educed p e alence o HIV in u ban se ings.
Based on he weakness o hese s udies designs, his e i-
dence was conside ed modes using a modi ied GRADE
app oach. Fu he , mode a e e idence was ound ha
mul i-componen HIV p e en ion p og ammes ha in-
clude NSP educe in e media e HIV isk beha iou .
The Ins i u e o Medicine epo highligh ed how almos
all published s udies o igina e in No h Ame ica, Wes e n
Eu ope, and Aus alia [24]. Two addi ional e iews we e
es ic ed o speci ic popula ions by geog aphical o
economical sou ce. Hong and Li summa ized e idence
om wo s udies conduc ed solely in China [31], while
Des Ja lais e al. ocused on 13 s udies o 11 NSPs wi h
high-co e age conduc ed in low/middle-income coun ies
[28]. In bo h cases, esul s om included s udies gene ally
suppo ed he e ec i eness o NSP in educing HIV. Des
Ja lais e al. epo ed a educ ion o HIV p e alence in
ou s udies ( om −3% o −15%), o es ima ed HIV inci-
dence in h ee s udies ( om −11/100 o −16/100 pe son-
yea s a isk), and o newly epo ed na ionwide cases in
h ee na ional epo s ( om −30% o −93.3%). Con e sely,
inc eases in HIV p e alence we e ound in wo s udies
( om +5.6% o +15.8%) and one na ional epo (+37.6%)
included in he e iew by Des Ja lais e al. The au ho s
conside ed ha , i high co e age is achie ed, NSP appea
o be as e ec i e in low/middle-income as in high-income
coun ies [28].
HCV p e alence and/o incidence
Eigh included e iews syn hesized he e idence on he
use o NSP in p e en ing HCV p e en ion in PWID. One
was a ed as being a low [12], h ee a unclea [24, 25, 29]
and ou a high isk o bias [28, 32–34], including wo
e iews ha used me a-analysis [32, 34]. The p opo ion
o s udies included exclusi ely in one o hese e iews was
88%. Bo h e iews wi h quan i a i e and quali a i e
syn hesis showed mixed esul s.
Re iews wi h me a-analysis Two e iews [32, 34], bo h
published in 2011 and a ed as being a high isk o bias,
used me a-analysis.
Hagan e al. [34] included 7 s udies ocusing on NSP
and HCV ou comes (6 coho and 1 case-con ol s udy),
all om No h Ame ica. The pooled analysis o all s udies,
using andom e ec s models and wi h all measu es o
e ec con e ed o ela i e isks, showed an inc ease in
he isk o HCV acquisi ion wi h NSP ( ela i e isk, 1.62;
95% CI: 1.04 o 2.52). The e was conside able he e ogen-
ei y (I
2
= 81%), bu no subg oup o sensi i i y analyses
we e pe o med, and s udy quali y was no explici ly
epo ed o conside ed in he analysis. Au ho s cau ioned
Fe nandes e al. BMC Public Heal h (2017) 17:309 Page 9 o 15